MY193688A - Anti-transthyretin antibodies - Google Patents
Anti-transthyretin antibodiesInfo
- Publication number
- MY193688A MY193688A MYPI2017702751A MYPI2017702751A MY193688A MY 193688 A MY193688 A MY 193688A MY PI2017702751 A MYPI2017702751 A MY PI2017702751A MY PI2017702751 A MYPI2017702751 A MY PI2017702751A MY 193688 A MY193688 A MY 193688A
- Authority
- MY
- Malaysia
- Prior art keywords
- ttr
- antibodies
- accumulation
- transthyretin
- amyloidosis
- Prior art date
Links
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications. (Figure 1A.1, Figure 1A.2 and Figure 1B)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562109002P | 2015-01-28 | 2015-01-28 | |
PCT/IB2016/050415 WO2016120810A1 (en) | 2015-01-28 | 2016-01-28 | Anti-transthyretin antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
MY193688A true MY193688A (en) | 2022-10-25 |
Family
ID=58951280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2017702751A MY193688A (en) | 2015-01-28 | 2016-01-28 | Anti-transthyretin antibodies |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR103549A1 (en) |
MY (1) | MY193688A (en) |
-
2016
- 2016-01-28 MY MYPI2017702751A patent/MY193688A/en unknown
- 2016-01-28 AR ARP160100239A patent/AR103549A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR103549A1 (en) | 2017-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501318A1 (en) | Anti-transthyretin antibodies | |
SA517381991B1 (en) | Anti-Transthyretin Antibodies | |
SA517381981B1 (en) | Anti-transthyretin antibodies | |
WO2018007924A3 (en) | Anti-transthyretin antibodies | |
MX2020003041A (en) | Anti-transthyretin antibodies. | |
WO2018007923A3 (en) | Anti-transthyretin antibodies | |
WO2018007922A3 (en) | Anti-transthyretin antibodies | |
MX2018008369A (en) | Anti-pro/latent myostatin antibodies and methods of use thereof. | |
PH12020550141A1 (en) | Antibody molecules to cd138 and uses thereof | |
SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
PH12018500887A1 (en) | Anti-htra1 antibodies and methods of use thereof | |
CL2020002468A1 (en) | Antibodies that bind to sortilin and inhibit the binding of progranulin (divisional application 92-2018) | |
MX2021016098A (en) | Humanized antibody molecules to cd138 and uses thereof. | |
EP4218817A3 (en) | Methods for treating metabolic diseases by inhibiting myostatin activation | |
MY193688A (en) | Anti-transthyretin antibodies | |
EA202090891A1 (en) | ANTIBODY MOLECULES AGAINST CD138 AND THEIR APPLICATION | |
PH12020552202A1 (en) | Antibody molecules to complement component 5 and uses thereof | |
EA202090898A1 (en) | ANTITRANSTYRETIN ANTIBODIES | |
BR112017007112A2 (en) | 1,2-benzothiazole compounds for the treatment of kidney disorders |